Jingxin Qiu, MD, PhD

Jingxin Qiu, MD, PhD

Roswell Park Cancer Institute
Staff Physician
Assistant Professor, Department of Pathology & Laboratory Medicine
Areas of Expertise: 
Neuropathology
Neuroscience
Special Interests: 
Identification of Malignant Glioma Biomarkers
Tumorigenesis
Board Certification: 
Anatomic Pathology and Neuropathology
Fellowship: 
07/2005-06/200 - Neuropathology Fellow, Department of Pathology, University of Florida
07/2009-06/2010 – Oncological Surgical Pathology Fellow, Roswell Park Cancer Institute
Residency: 
07/2003-06/2005 - Anatomic Pathology, University of Florida
Education and Training: 
2001 - Ph.D. University of Texas Medical Branch at Galveston
1992 - M.D. - Beijing Medical University
Publications
  • Shao H, Gao C, Tang H, Zhang H, Roberts LR, Hylander BL, Repasky EA, Ma WW, Qiu J, Adjei AA, Dy GK, Yu C. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo. Journal of hepatology 2012; 561:176-183
  • Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB. A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies. Blood 2011; 11815:4070-4078
  • Dyer LM, Schooler KP, Ai L, Klop C, Qiu J, Robertson KD, Brown KD. The transglutaminase 2 gene is aberrantly hypermethylated in glioma. Journal of neuro-oncology 2011; 1013:429-440
  • Qiu J , Kulkarni S , Chandrasekhar R , Rees M , Hyde K , Wilding G , Tan D , Khoury T. Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. American journal of clinical pathology 2010; 1345:813-819